OAM
HTGM

Oxford Asset Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Oxford Asset Management’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-224
Closed -$81K – 1965
2017
Q4 		$81K Buy
+224
New +$85.5K ﹤0.01% 1540

Other funds holding HTGM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Oxford Asset Management's HTGM Position: Q1 2018 in Review

Oxford Asset Management sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q1 2018, closing a stake of 224 shares — an estimated $81K sold.

Oxford Asset Management first reported a position in HTGM in Q4 2017 and held it in 1 quarter. The position peaked at $81K in Q4 2017. 41 funds tracked by Wall St. Rank hold HTGM as of Q1 2018.

  • Oxford Asset Management reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Oxford Asset Management sold 224 HTG Molecular Diagnostics, Inc. Common Stock shares in Q1 2018, an estimated $81K.
  • Oxford Asset Management first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Oxford Asset Management's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $81K in Q4 2017.
  • 41 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.